Part Details | CEPHALEXIN CAPSULES
6505-01-269-9179
Alternate Parts: NDC67877021905, NDC67877-0219-05, NDC42291020950, NDC42291-0209-50, 1450271, 6505NCM173356, NDC68180012202, NDC68180-0122-02, NDC00093314705, NDC00093-3147-05, 6505-01-269-9179, 01-269-9179, 6505012699179, 012699179
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | DEC 23, 1987 | 01-269-9179 | 31387 ( CEPHALEXIN CAPSULES ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-269-9179
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC67877-0219-05 | 7S6Y9 | ASCEND LABORATORIES, LLC |
| NDC42291-0209-50 | 4QGW8 | AVKARE, INC. |
| 1450271 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM173356 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| NDC68180-0122-02 | 673J1 | LUPIN PHARMACEUTICALS, INC. |
| NDC00093-3147-05 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
Technical Data | NSN 6505-01-269-9179
| Characteristic | Specifications |
|---|---|
| CAPSULE TYPE | SOFT |
| CAPSULE CONTENT FORM | POWDER |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB500.000 MILLIGRAMS CEPHALEXIN |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER TYPE | BOTTLE |
| CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 500.000 |
| SPECIAL FEATURES | EACH CAPSULE, FOR ORAL ADMINISTRATION,CONTAINS 500 MILLIGRAMS (MG) OF CEPHALEXIN AS THE ACTIVE INGREDIENT. IN BOTTLES OF 500 TABLETS. STORE AT 20-25 C (68-77 F); ?SEE USP CONTROLLED ROOM TEMPERATURE| |
| PROTECTIVE STORAGE FEATURE | CONTROLLED ROOM TEMPERATURE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEPHALEXIN 500 MG CAPSULE 500S |